About PNP Therapeutics
Frank R. Hunt, MS, MBA
Mr. Hunt serves as the Chief Executive Officer of the Company through an arrangement with SE bioStrategies, Inc., a new enterprise formation and management firm specializing in the early-stage, strategic development of university-based technologies and associated commercial opportunities within the life sciences industry. Examples of recent companies founded and managed include ErythroGen, Inc. (artificial blood substitute and gene therapy) and Sláinte Bioceuticals, Inc. (chemotherapeutic agents), serving as President/CEO of both. Prior work experience includes a range of senior roles in executive/general management within firms such as Murex Corporation/International Murex, Baxter Healthcare and TM Analytic. Mr. Hunt has a Bachelor of Science Degree from Valparaiso University, Master of Science Degree in Virology and Immunology from Georgia State University, and a Master of Business Administration in Marketing from the J. Mack Robinson School at Georgia State University, Executive MBA Program.